Mentions
Extended reach
Total likes
Video views
AI synopsis
The enthusiasm and focus on the therapeutic implications, such as references to mitigating radiation-induced cancers and the role of senolytic therapy, illustrate deep engagement and recognition of the research's potential importance, though some comments remain general summaries. The tone underscores a positive outlook on advances in aging and cancer prevention.
Most discussions express strong support and enthusiasm for the research findings, emphasizing the significance of the potential impact on cancer prevention.
The discussions demonstrate high interest, referencing specific details about the research and its implications, indicating engagement with the topic.
Many posts mention specific aspects like the use of ABT-263 and its effects, showing a deep understanding and active interest, though some are more straightforward summaries which indicates moderate engagement.
The discussions highlight the potential of the research to influence future cancer treatments and aging studies, suggesting high perceived impact.
#PaperoftheDay: "Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice" DOI ⬇️ https://t.co/L32U9OEmcF #aging #cancer #research #openaccess #peerreview #publishing
Longevity & Aging Series (S3, E4): In this #episode, Dr. Shubhankar Suman @LombardiCancer discusses his #research, “Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice.” https://t.co/ZcOYZm5PT4 #aging #oa
#PaperSpotlight: A new #research paper was #published on January 8, 2025, titled "Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice." @gumedcenter https://t.co/L32U9OEmcF #aging #quote #cancer #oa https://t.co/PGdhPfIqcl
Longevity & Aging Series (S3, E4): In this #episode, Dr. Shubhankar Suman @LombardiCancer discusses his #research, “Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice.” https://t.co/ZcOYZm5PT4 #aging #oa
Longevity & Aging Series (S3, E4): In this #episode, Dr. Shubhankar Suman @LombardiCancer discusses his #research, “Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice.” https://t.co/ZcOYZm5PT4 #aging #oa
In this episode of the Longevity & Aging Series, Dr. Shubhankar Suman discusses how senolytic agent ABT-263 can mitigate gastrointestinal cancer development caused by ionizing radiation, highlighting potential…
AgingUS published this research paper on January 8 2025 in Volume 17 Issue 1 entitled Senolytic agent ABT-263 mitigates low and high-LET radiation induced gastrointestinal cancer in mice by researchers from Georgetown…
Longevity & Aging Series (S3, E4): In this #episode, Dr. Shubhankar Suman @LombardiCancer discusses his #research, “Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice.” https://t.co/ZcOYZm5PT4 #aging #oa
Longevity & Aging Series (S3, E4): In this #episode, Dr. Shubhankar Suman discusses his #research, “Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice.”
Longevity & Aging Series (S3, E4): In this #episode, Dr. Shubhankar Suman @LombardiCancer discusses his #research, “Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice.” https://t.co/ZcOYZm5PT4 #aging #oa
Longevity & Aging Series (S3, E4): In this #episode, Dr. Shubhankar Suman discusses his #research, “Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice.” www.youtube.com/watch?v=ClLO... #aging #openaccess #publishing #series
Longevity & Aging Series (S3, E4): In this #episode, Dr. Shubhankar Suman @LombardiCancer discusses his #research, “Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice.” https://t.co/ZcOYZm5PT4 #aging #oa
Longevity & Aging Series (S3, E4): In this #episode, Dr. Shubhankar Suman @LombardiCancer discusses his #research, “Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice.” https://t.co/ZcOYZm5PT4 #aging #oa
Longevity & Aging Series (S3, E4): In this #episode, Dr. Shubhankar Suman discusses his #research, “Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice.”
Longevity & Aging Series (S3, E4): In this #episode, Dr. Shubhankar Suman @LombardiCancer discusses his #research, “Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice.” https://t.co/ZcOYZm5PT4 #aging #oa
Longevity & Aging Series (S3, E4): In this #episode, Dr. Shubhankar Suman from Georgetown University discusses his #research: “Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice.” www.youtube.com/watch?v=ClLO... #aging #oa
#PaperSpotlight: A new #research paper was #published on January 8, 2025, titled "Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice." @gumedcenter https://t.co/L32U9OEmcF #aging #quote #cancer #oa https://t.co/PGdhPfIqcl
#AgingResearch: This #research paper was #published in Volume 17, Issue 1, titled "Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice." #PressRelease ⬇️ aging-us.com/news-room/se... #aging #cancer #oa #press #publishing
#PaperoftheDay: "Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice" DOI ⬇️ https://t.co/L32U9OEmcF #aging #cancer #research #openaccess #peerreview #publishing
#AgingResearch: "Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice" from Volume 17, Issue 1. DOI ⬇️ doi.org/10.18632/agi... #aging #oncology #research #openaccess #peerreview #publishing
" Georgetown University Medical Center https://doi.org/10.18632/aging.206183 #aging #senolytics #carcinogenesis #inflammation #gastrointestinalcancer ...
Aging. doi.org/10.18632/aging.206183. Currently rated 5.0 by 1 person. Posted in: Medical Research News | Medical Condition News. Comments (0).
AU